UK markets open in 5 hours 43 minutes
  • NIKKEI 225

    +176.15 (+0.67%)

    0.00 (0.00%)

    +0.54 (+0.70%)

    +5.80 (+0.36%)
  • DOW

    -329.60 (-1.11%)

    +499.96 (+2.85%)
  • CMC Crypto 200

    +13.18 (+3.04%)
  • ^IXIC

    -65.00 (-0.60%)
  • ^FTAS

    -7.23 (-0.19%)

Outlook on the Acne Treatment Global Market, to 2027 - Rising Public Knowledge of Cosmetic Acne Treatments is Driving Growth

·4-min read
Company Logo
Company Logo

Dublin, Sept. 22, 2022 (GLOBE NEWSWIRE) -- The "Global Acne Treatment Market, By Therapeutic Class, By Formulation, By Type, By Acne Type, By Distribution Channel, By Company, By Region, Competition Forecast & Opportunities, 2027" report has been added to's offering.

The global acne treatment market is projected to grow at an impressive CAGR in the forecast period, 2023-2027. Acne is a skin condition where dead skin cells, debris, and dust clog oil glands and hair follicles on the skin's surface. Acne vulgaris, the disorder's other name, has four main causes: inflammation, propionibacterium bacteria, excessive sebum production, and hyperkeratinization.

Factors such as severe social stigma associated with acne, growing public knowledge of cosmetic acne treatments, and increased accessibility of these treatments are driving the demand for the global Acne Treatment Market. Also, the adoption of unhealthy eating habits and growing pollution levels that are increasing the level of dirt, dust, and pollutants in the environment are increasing the cases of acne in individuals.

The global acne treatment market is segmented into therapeutic class, formulation, type, acne type, distribution channel, regional distribution, and competitive landscape. Based on therapeutic class, the market is fragmented into retinoids, antibiotics, hormonal drugs, anti-inflammatory drugs, chemical peels, and others. Antibiotics are expected to hold the largest market share in the forecast period, 2023-2027. Their high efficiency in exudate management and rise in approvals in acne treatment is driving the segment demand.

Based on acne type, the market is divided into cystic acne, postsurgical/wound acne, comedonal acne, and inflammatory acne. Inflammatory acne is anticipated to capture the highest market share in the forecast period, 2023-2027. Inflammatory acne is a skin disorder that occurs when pores clog well beneath the skin. The condition gets worse if germs start to grow inside these lesions, turning the affected area of skin red and swollen. The growing incidence of inflammatory acne cases worldwide is driving the segment demand.

The major market players operating in the Global Acne Treatment market are Novan Inc., Vyome Biosciences Pvt. Ltd., Foamix Pharmaceuticals Ltd., BioPharmX Corporation, Paratek Pharmaceuticals, Inc., Sun Pharmaceuticals Ltd., Hegde & Hegde Pharmaceutica LLP, Mankind Pharmaceuticals Ltd., Cipla Ltd., Glenmark Pharmaceuticals Limited, Stiefel Laboratories Inc., Galderma S.A., Lumenis Ltd., Cutera, Inc., Alma Lasers Ltd, among others.

Years considered for this report:

  • Historical Years: 2017-2020

  • Base Year: 2021

  • Estimated Year: 2022E

  • Forecast Period: 2023F-2027F

Objective of the Study:

  • To analyze the historical growth in the market size of global acne treatment market from 2017 to 2021

  • To estimate and forecast the market size of global acne treatment market from 2022E to 2027F and growth rate until 2027F

  • To classify and forecast global acne treatment market based on therapeutic class, formulation, type, acne type, distribution channel, regional distribution and competitive landscape

  • To identify dominant region or segment in the global acne treatment market

  • To identify drivers and challenges for global acne treatment market

  • To examine competitive developments such as expansions, mergers & acquisitions, etc., in global acne treatment market

  • To identify and analyze the profile of leading players operating in global acne treatment market

  • To identify key sustainable strategies adopted by market players in global acne treatment market

Key Topics Covered:

1. Service Overview

2. Research Methodology

3. Executive Summary

4. Impact of COVID-19 on Global Acne Treatment Market

5. Voice of Customer

6. Global Acne Treatment Market Outlook
6.1. Market Size & Forecast
6.1.1. By Value
6.2. Market Share & Forecast
6.2.1. By Therapeutic Class (Retinoids, Antibiotics, Hormonal Drugs, Anti-Inflammatory Drugs, Chemical Peels and Others)
6.2.2. By Formulation (Topical Medications, Oral Medications and Injectables)
6.2.3. By Type (Prescription Medicines and Over-The-Counter Medicines)
6.2.4. By Acne Type (Cystic Acne, Postsurgical/Wound Acne, Comedonal Acne, Inflammatory Acne)
6.2.5. By Distribution Channel (Hospitals, Retail Stores, Pharmacies & Drug Stores, and E-Commerce)
6.2.6. By Company (2020)
6.2.7. By Region (North America, Europe, Asia-Pacific, South America, Middle East & Africa)
6.3. Market Map

7. North America Acne Treatment Market Outlook

8. Europe Acne Treatment Market Outlook

9. Asia-Pacific Acne Treatment Market Outlook

10. Middle East and Africa Acne Treatment Market Outlook

11. South America Acne Treatment Market Outlook

12. Market Dynamics
12.1. Drivers
12.2. Challenges

13. Market Trends & Developments

14. Competitive Landscape
14.1. Competition Outlook
14.2. Global Players Profiled (Leading Companies)
14.2.1. Novan Inc.
14.2.2. Vyome Biosciences Pvt. Ltd.
14.2.3. Foamix Pharmaceuticals Ltd.
14.2.4. BioPharmX Corporation
14.2.5. Paratek Pharmaceuticals, Inc.
14.2.6. Sun Pharmaceuticals Ltd.
14.2.7. Hegde & Hegde Pharmaceutica LLP
14.2.8. Mankind Pharmaceuticals Ltd.
14.2.9. Cipla Ltd.
14.2.10. Glenmark Pharmaceuticals Limited
14.2.11. Stiefel Laboratories Inc.
14.2.12. Galderma S.A.
14.2.13. Lumenis Ltd.
14.2.14. Cutera, Inc.
14.2.15. Alma Lasers Ltd.

15. Strategic Recommendations

16. About Us & Disclaimer

For more information about this report visit

CONTACT: CONTACT: Laura Wood,Senior Press Manager For E.S.T Office Hours Call 1-917-300-0470 For U.S./ CAN Toll Free Call 1-800-526-8630 For GMT Office Hours Call +353-1-416-8900